X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SANOFI INDIA SUVEN LIFE/
SANOFI INDIA
 
P/E (TTM) x 18.0 38.2 47.1% View Chart
P/BV x 3.6 7.2 50.1% View Chart
Dividend Yield % 0.6 0.5 119.9%  

Financials

 SUVEN LIFE   SANOFI INDIA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
SANOFI INDIA
Dec-17
SUVEN LIFE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs2514,945 5.1%   
Low Rs1553,901 4.0%   
Sales per share (Unadj.) Rs49.11,081.8 4.5%  
Earnings per share (Unadj.) Rs9.7141.6 6.9%  
Cash flow per share (Unadj.) Rs11.4185.9 6.1%  
Dividends per share (Unadj.) Rs1.5033.00 4.5%  
Dividend yield (eoy) %0.70.7 99.1%  
Book value per share (Unadj.) Rs60.3868.8 6.9%  
Shares outstanding (eoy) m127.2823.03 552.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.1 101.0%   
Avg P/E ratio x20.931.2 66.8%  
P/CF ratio (eoy) x17.823.8 74.9%  
Price / Book Value ratio x3.45.1 66.1%  
Dividend payout %15.423.3 66.2%   
Avg Mkt Cap Rs m25,825101,862 25.4%   
No. of employees `0001.13.2 33.1%   
Total wages/salary Rs m6133,685 16.6%   
Avg. sales/employee Rs Th5,832.67,691.9 75.8%   
Avg. wages/employee Rs Th571.51,137.7 50.2%   
Avg. net profit/employee Rs Th1,153.81,006.5 114.6%   
INCOME DATA
Net Sales Rs m6,25324,914 25.1%  
Other income Rs m233807 28.8%   
Total revenues Rs m6,48525,721 25.2%   
Gross profit Rs m1,9825,372 36.9%  
Depreciation Rs m2131,022 20.9%   
Interest Rs m4611 420.9%   
Profit before tax Rs m1,9555,146 38.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,886 38.1%   
Profit after tax Rs m1,2373,260 37.9%  
Gross profit margin %31.721.6 147.0%  
Effective tax rate %36.736.6 100.2%   
Net profit margin %19.813.1 151.2%  
BALANCE SHEET DATA
Current assets Rs m5,62214,432 39.0%   
Current liabilities Rs m1,1686,010 19.4%   
Net working cap to sales %71.233.8 210.8%  
Current ratio x4.82.4 200.5%  
Inventory Days Days8161 133.7%  
Debtors Days Days3628 126.1%  
Net fixed assets Rs m3,3257,991 41.6%   
Share capital Rs m127230 55.3%   
"Free" reserves Rs m7,54719,778 38.2%   
Net worth Rs m7,67420,008 38.4%   
Long term debt Rs m140-   
Total assets Rs m9,13527,770 32.9%  
Interest coverage x43.2468.8 9.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 76.3%   
Return on assets %14.011.8 119.2%  
Return on equity %16.116.3 98.9%  
Return on capital %26.025.8 101.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,0666,306 80.3%   
Fx outflow Rs m2,0015,257 38.1%   
Net fx Rs m3,0651,049 292.2%   
CASH FLOW
From Operations Rs m6994,351 16.1%  
From Investments Rs m-6-787 0.8%  
From Financial Activity Rs m-577-1,884 30.6%  
Net Cashflow Rs m1161,680 6.9%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 0.0 14.4 -  
FIIs % 0.0 14.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.5 347.6%  
Shareholders   37,287 15,184 245.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   AUROBINDO PHARMA  MERCK LTD  GSK PHARMA  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Dec 12, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS